Mydecine Signs LOI with The Newly Institute to Provide Psychedelic-Assisted Psychotherapy to Patients under Health Canada’s Special Access Program
Under Mydecine's recently announced Special Access Support and Supply Program, the company will supply cGMP Psilocybin and MDMA to The...